Increase of tyrosine hydroxylase levels and activity during morphine withdrawal in the heart

被引:11
作者
González-Cuello, A [1 ]
Milanés, MV [1 ]
Laorden, ML [1 ]
机构
[1] Univ Murcia, Sch Med, Equip Cellular & Mol Pharmacol, Murcia, Spain
关键词
Fos; morphine withdrawal; heart; tyrosine hydroxylase; western blot;
D O I
10.1016/j.ejphar.2004.11.009
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Our previous studies have shown an enhanced activity of the noradrenergic pathways innervating the heart in rats withdrawn from morphine. However, the possible adaptive changes that can occur in these pathways during morphine dependence are not known. We studied the alterations in tyrosine hydroxylase (the rate-limiting enzyme in catecholamines biosynthesis) and tyrosine hydroxylase activity in the heart (right and left ventricle) during morphine withdrawal. In the same paradigm, we measured Fos expression as a marker of neuronal activation and the normetanephrine/noradrenaline ratio (an index of noradrenaline turnover). We evaluated the levels of tyrosine hydroxylase and Fos by quantitative Western blot analysis, and noradrenaline turnover using high-performance liquid chromatography (HPLC). Dependence on morphine was induced by a 7-day s.c. implantation of morphine pellets. Morphine withdrawal was precipitated on day 8 by an injection of naloxone (5 mg/kg s.c.). The results show a significant increase in tyrosine hydroxylase levels and activity in the right and left ventricle 30 or 90 min after naloxone precipitated withdrawal in parallel with an increase in noradrenaline turnover. Morphine withdrawal also induced an increase in the Fos expression, which indicates an activation of cardiac cellular activity. Our results suggest that an increase in tyrosine hydroxylase protein levels and tyrosine hydroxylase enzyme activity might contribute to the enhanced noradrenergic activity in the heart in response to morphine withdrawal. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:119 / 128
页数:10
相关论文
共 39 条
[1]
THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[2]
Armour J.A., 1991, Journal of Cardiovascular Electro-physiology, V2, P331, DOI [DOI 10.1111/J.15408167.1991.TB01330.X, DOI 10.1111/J.1540-8167.1991.TB01330.X]
[3]
PEPTIDERGIC MODULATION OF INSITU CANINE INTRINSIC CARDIAC NEURONS [J].
ARMOUR, JA ;
HUANG, MH ;
SMITH, FM .
PEPTIDES, 1993, 14 (02) :191-202
[4]
INFLUENCE OF NEUROTROPHIC FACTORS ON MORPHINE-INDUCED AND COCAINE-INDUCED BIOCHEMICAL-CHANGES IN THE MESOLIMBIC DOPAMINE SYSTEM [J].
BERHOW, MT ;
RUSSELL, DS ;
TERWILLIGER, RZ ;
BEITNERJOHNSON, D ;
SELF, DW ;
LINDSAY, RM ;
NESTLER, EJ .
NEUROSCIENCE, 1995, 68 (04) :969-979
[5]
Genetic analysis of drug addiction: the role of cAMP response element binding protein [J].
Blendy, JA ;
Maldonado, R .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (02) :104-110
[6]
Boundy VA, 1998, J NEUROSCI, V18, P9989
[7]
Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: Comparisons between acute drug treatment and a drug challenge in sensitized animals [J].
Curran, EJ ;
Akil, H ;
Watson, SJ .
NEUROCHEMICAL RESEARCH, 1996, 21 (11) :1425-1435
[8]
Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal [J].
Fuertes, G ;
Laorden, ML ;
Milanés, MV .
NEUROENDOCRINOLOGY, 2000, 71 (01) :60-67
[9]
FOS FAMILY MEMBERS SUCCESSIVELY OCCUPY THE TYROSINE-HYDROXYLASE GENE AP-1 SITE AFTER NERVE GROWTH-FACTOR OR EPIDERMAL GROWTH-FACTOR STIMULATION AND CAN REPRESS TRANSCRIPTION [J].
GIZANGGINSBERG, E ;
ZIFF, EB .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (02) :249-262
[10]
Activation of c-fos expression in the heart after morphine but not U-50,488H withdrawal [J].
González-Cuello, A ;
Milanés, MV ;
Castells, MT ;
Laorden, ML .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (04) :626-633